A precision therapeutics biotech company, leveraging our key expertise in both early target discovery & targeted delivery, as well drug/compound/molecule development The drugs prescribed are on trial and error methods, where some drug show their effects and some don't with varying side effects due to different genetic makeup of each individual. With advent of high throughput sequencing of human genome including prenatal (prebirth) genome, we are able to identify variations in genetic makeup, and henceforth providing a platform to identify the risk of disease even before birth, and providing personalized medication. In a nutshell, this will implement a diagnostic model customizing healthcare with decision making, medical practices, products and protocols being tailor made for the individual patients. It will also help in identifying new variations causing disease in Indian population which can serve as biomarkers and novel drug targets.
